CURRICULUM VITAE
Samuel T. Thompson,
M.D.
Urology
of Indiana, LLC
Birthdate: June 27, 1960
Education: Indiana University (BS) 1978-1982
Bloomington, Indiana
Indiana University School of Medicine 1982-1986
MD Degree
Indianapolis, Indiana
Residency: General Surgery 1986-1988
Case Western Reserve University
Cleveland, Ohio
Residency: Urology 1988-1992
Case Western Reserve University
Cleveland, Ohio
Fellowship: Male Reproductive Medicine & Surgery 1992-1993
Baylor College of Medicine
Houston, Texas
Military Service: Indiana Army National Guard 1984-1986
2 LT Medical Service Corp.
Indianapolis, Indiana
Ohio Army National Guard 1986-1991
CPT Medical Corp.
Cleveland, Ohio
Certification: American Board of Urology 2/19/95
Licensure: State of Indiana #01041048 5/14/93
State of Ohio #35-05-5535
Academic Appointments: Instructor 3/1/93-6/30/93
Department of Urology
Baylor College of Medicine
Houston, Texas
Assistant Clinical Professor 1993-1996
Department of Urology
Indiana University School of Medicine
Indianapolis, Indiana
Adjunct Faculty Appointment 1995 - present
College of Pharmacy & Health Sciences
Butler University
Indianapolis, Indiana
Professional Organizations: American Association of Clinical Urologists 1990
Fellow, American College of Surgeons 1996
American Medical Association 1994
American Society of Andrology 1993
American Society of Reproductive Medicine 1995
Indiana State Medical Association 1993
Marion County Medical Society 1993
North Central Section - AUA 1995
Society for the Study of Male Reproduction 1993
Society of Reproductive Surgeons 1995
Christian Medical & Dental Society 1997
Hospital Staff Appts.: Methodist Hospital, Indianapolis IN (active 1993)
Rehabilitation Hospital, Indianapolis IN (consulting 1993)
Riverview Hospital, Noblesville IN (active 1993)
St. Vincent Hospital, Indianapolis IN (provisional 1993)
Indiana Surgery Center, Indianapolis, IN (6/95)
Columbia Women's Hospital, Indianapolis IN (active 2/96)
Community Hospitals, Indianapolis, IN (courtesy)
Community Hospital South, Indianapolis, IN (courtesy)
St. Francis Hospital, Indianapolis, IN (provisional 6/97)
Hendricks Community Hospital, Danville, IN (courtesy 3/98)
Johnson Memorial Hospital, Franklin, IN (provisional 5/98)
Medical Practice: Private - 100% Urology
Office Locations: 1801 N. Senate Blvd., Suite 655
Indianapolis IN 46202
317-924-1361
Women’s Hospital Medical Office Bldg.
8091 Township Line Road, Suite 205
Indianapolis, IN 46260
317-876-7906
Associates: Phillip G. Mosbaugh, M.D.
Peter M. Knapp, M.D.
John W. Scott, M.D.
David W. Hollensbe, M.D.
Glen A. Brunk, M.D
Daniel B. Salvas, M.D.
Jeffery D. Vaught, M.D.
Philip W. Woodbury, MD
Teresa D. Beam, M.D.
Richard M. Bennett, III, M.D.
W. Terry Jones, M.D.
Neale A. Moosey, M.D.
David M. Scheidler, M.D.
David B. Stuhldreher, M.D.
Home Address: 8111 Westfield Blvd.
Indianapolis, IN 46240
317-465-9861
Publications:
Thomalla JV, Thompson ST, Rowland RG, Mulcahy JJ: Infectious complications of penile prosthetic implants. J Urol 138:65-67, 1987.
Thompson ST: Nonseminomatous germ cell tumors. IN Resnick MI and Benson MA (eds): Manual of Clinical Problems in Urology , Boston: Little, Brown and Co., pgs 222-224, 1988.
Thompson ST: Ureteroceles. IN Resnick MI and Benson MA (eds): Manual of Clinical Problems in Urology , Boston: Little, Brown and Co., pgs 96-98, 1988.
Resnick MI, Thompson ST: Update on urologic advances and controversies. Infections in Urol 3:8-12, 1990.
Kursh ED, Jones WT, Thompson ST, Nelson D, Miraldi F: A dynamic dual isotope radionuclear method of quantifying penile blood flow. J Urol 147:1524-1529, 1992.
Miraldi F, Nelson D, Jones WT, Thompson ST, Kursh ED: A dual radio-isotope technique for the evaluation of penile blood flow during tumescence. J Nuc Med 33:41-46, 1992.
Thompson ST, Kursh ED: Delayed spontaneous rupture of an ileocolonic neobladder. J Urol 148:1890-1891, 1992.
Honig SC, Thompson ST, Lipshultz LI: Reassessment of male factor infertility, including the varicocele, sperm penetration assay, semen analysis, and in vitro fertilization. In Azziz R (ed): Current Opinion in Obstretics and Gynecology . Philadelphia: Current Science, Vol 5 pgs 245-251, 1993.
Thompson ST: Preventable causes of male infertility. World J Urol 11:111-119, 1993.
Thompson ST and Resnick MI: Screening for prostate cancer. In Lepor H and Lawson RK (eds): Prostate Diseases. Philadelphia: W.B. Saunders Company. Chapter 23, pgs 293-304, 1993.
Thompson ST, Grillis MA, Wolkoff LH, Katzin WE: Transverse testicular ectopia in a man with persistent müllerian duct syndrome. Arch of Pathol & Lab Med 118:752-755, July 1994.
Thompson ST: Prevention of Male Infertility: An Update. Urol Clin N Am 21:365-376, August 1994.
Thompson ST, Resnick MI: Stone surgery. IN Cohen MS and Resnick MI (eds): Reoperative Urology. Boston: Little, Brown and Company, Chapter 6, pgs 43-52, December 1994.
Thompson ST, Honig SC, Lipshultz LI: Sexual and ejaculatory dysfunction as a cause of male infertility. IN Keye WR, et al. (ed): Infertility: Evaluation and Treatment. Philadelphia: W.B. Saunders Company, Chapter 44, pgs 671-685, December 1994.
Thompson ST: Bringing preventive medicine to male infertility. Contemp Urol Vol. 6: 37-48, December 1994.
Meeting Presentations:
A comparison between self-injection therapy and external vacuum pump devices for the treatment of impotence
North Central Section, AUA, Colorado Springs CO, October 1990
Traumatic hypospadias as a complication of indwelling urethral catheters
North Central Section, AUA, Colorado Springs CO, October 1990
Transverse testicular ectopis in a man with persistent müllerian duct syndrome
Ohio Urologic Association, Columbus OH, March 1991
Secondary urethral diverticula and urethral fistula in spinal cord injury patients
North Central Section, AUA, Scottsdale AZ, November 1991
Efficacy of transurethral resection of ejaculatory ducts in males with low-volume ejaculate v normal-volume ejaculate
AUA Annual Meeting, San Antonio TX, May 1993
Pathologic epididymal obstruction unrelated to vasectomy: results with microsurgical reconstruction
AUA Annual Meeting, San Antonio TX, May 1993
Repeated sequential rectal probe electroejaculation in a short interval improves semen quality in anejaculatory men
AUA Annual Meeting, San Antonio TX, May 1993
Office evaluation of the infertile male
American College of OB/GYN, April 1994
Treatment of leukocytospermia in a population of infertile males
North Central Section, AUA, Minneapolis, MN, September 1995
Infertility Update
Lectures:
Impotence
Internal Medicine Residents, Methodist Hospital of Indiana, Indianapolis, IN August 1993.
Male Factor Infertility
RESOLVE Inc. Indiana Chapter, Indianapolis, IN, March 1994.
Impotence
MetroHealth Medical Staff, Indianapolis, IN, May 12, 1994.
Prostate Cancer
Tumor Board, Methodist Hospital of Indiana, Indianapolis, IN, June 29, 1994.
Sexually Transmitted Disease
Family Practice Residents, Indianapolis, IN, July 26, 1994.
Impotence
Inservice, Indianapolis, IN, September 9, 1994
Update on Evaluation and Treatment of Impotence
Grand Rounds, Reid Hospital, Richmond, IN, September 28, 1994
Fertility in Spinal Cord Injury Patients
Inservice, Rehabilitation Hospital, Indianapolis, IN, September 30, 1994
Office Evaluation of the Impotent Patient
Urology Update for Primary Care Physician: 1994, Indianapolis, IN, December 10, 1994
Surgical Alternatives for the Managment of Impotence
Urology Update for Primary Care Physician: 1994, Indianapolis, IN, December 10, 1994
Butler Physician Assistant Lecture, April 1995
Male Infertility
Medical Staff of Union Hospital, Terre Haute, May 1995
Office Evaluation of the Impotent Patient
Indiana University Medical Center, Indianapolis, IN, February 10, 1996
Hormonal Treatment of Erectile Dysfunction
Rotary Club, Indianapolis, IN May 1, 1996
Hormonal Treatment of Erectile Dysfunction
Methodist Health Group Family Physician Workshop, Indianapolis, IN, 5-10-96
Impotence
Grand Rounds, Methodist Hospital of Indiana, Indianapolis, IN
May 14, 1997
Sexual Function and Fertility
SCI Seminar, Rehabilitation Hospital of Indiana, Indianapolis, IN
June 21, 1997
Correctable Causes of Male Infertility
Indianapolis,
IN, August 13, 1997
Preserving Fertility in Male Oncology Patients
Tumor Board, Methodist Hospital of Indiana, Indianapolis, IN
November 5, 1997
Noninvasive Treatments for Impotence
Grand Rounds, Methodist Hospital of Indiana, Indianapolis, IN
January
8, 1998
Hospital Articles:
Not for Men Only...Protecting Male
Fertility, Regarding Women, The
Women’s Hospital Indianapolis,
Winter 1995.
Poster Sessions:
Comparison of Tru-Trax text results in fresh and post-thaw donor semen samples
American Fertility Society Meeting, Montreal, Quebec, Canada, October 1993.
Increased incidence of renal anomalies, other than agenesis, in infertile men with congenital absence of the vas deferens (presented by David Ragan, resident)
North Central Section, AUA, Tucson, AZ, October 1996.
Congenital bilateral absence of the vas deferens as the only presenting sign in a patient homozygous for the delta F508 gene mutation (presented by Bradley Bell, resident)
North Central Section, AUA, Monterey, CA, September 1997.
Video
Presentations:
New Treatments for Male Infertility (subzonal sperm injection)
Urology Update for Primary Care Physician: 1994, Indianapolis, IN, December 10, 1994
Testis Biopsy Conferences, Methodist Hospital, 9-3-93, 10-29-93, 12-3-93, 1-28-94, 2-25-94, 4-15-94, 7-8-94, 8-12-94, 10-21-94, 12-9-94, 1-13-95, 3-10-95, 5-12-95, 9-8-95, 3-8-96, 6-3-96
Patient Education Seminars:
Infertility
Fort Wayne, IN, May 1994
Infertility
Fort Wayne, IN, June 1995
Urology Clinical Trials:
Prospective randomized trial of shock wave lithotripsy and percutaneous nephrostolithotomy for lower pole nephrolithiasis
Prospective randomized trial to evaluate patient comfort with regards to size of indwelling ureteral stents
A quinalone in the treatment of complicated or recurrent urinary tract infections in elderly patients. An open-label, randomized, comparative, multi-center study versus ciprofloxacin tablets
Evaluation of tumor associated biomarkers in the diagnosis and management of prostate cancer
Evaluation of biomarkers in the diagnosis and management of prostate disease
Intravesical chemotherapy in patients with carcinoma in situ of the bladder who have failed or have recurrence following treatment with BCG
Intravesical agent in patients with transitional cell carcinoma of the bladder
Phase III study of an oral agent versus intravesical BCG in adult patients with BCG-naive bladder carcinoma in situ
Randomized, multi-center, double-blind, double-dummy comparative trial of a trovafloxacin and ofloxacin for the treatment of bacterial prostatitis
Randomized prospective study comparing intermittent versus continuous androgen deprivation with chemotherapy in clinical stage D2 prostate cancer
Hormonal therapy versus placebo in early prostate cancer
Long-term safety, tolerability and clinical efficacy of a new anticholinergic medication. A Phase III open, multi-national study in patients with detrusor overactivity, symptoms of frequency, urge incontinence and/or urgency. 1997 – June 1998
Randomized, double-blind, multi-center, Phase II/III comparison of a new quinolone to Ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis. August 1997 – June 1998
An open label 12-month trial of oral phentolamine in patients with mild to moderate erectile dysfunction. September 1997 – January 1999
A randomized double-blind comparative trial of an anti-androgen vs. placebo in patients with early prostatic cancer. July 1997 - present
An international Phase II randomized, double-blind multi-center study to determine the safety and efficacy of three different doses of a new imidazole in patients with rising prostate specific antigen levels after definitive treatment. July 1997 – February 1998
A randomized, double-blind, placebo-controlled, two-year parallel group study of the efficacy and safety of a new 5-alpha reductase inhibitor in the treatment and prevention of progression of benign prostatic hyperplasia. September, 1997 - present
A phase II/III, double-blind, placebo controlled dose finding study of the efficacy of a new selective alpha blocker in patients with symptomatic benign prostatic hyperplasia. 1998 – present
A double-blind study of clinical efficacy and tolerability/safety of an anticholinergic prolonged release capsule and an anticholinergic immediate release tablets versus placebo in patients with symptoms of over-active bladder. February 1999 – present
A double-blind, phase III study of a new quinolone compound versus a marketed quinolone in the treatment of chronic bacterial prostatitis. February 1999 – present
A multi-center, randomized, double-blind, parallel group evaluation of the safety and efficacy, and the effect on coagulation parameters and clotting factors, or 3 different daily doses of a medication used in patients with interstitial cystitis. 1998 – present
A randomized, double-blind, comparative trial of an antiandrogen versus placebo each in combination with castration as second-line therapy for patients with asymptomatic metastatic prostate cancer. 1998 – present
A multi-center, randomized, open label trial to compare bone mineral density and fate free mass in men given either a LHRH agonist or an antiandrogen for the treatment of prostate cancer. 1998 – present
A multi-center pilot study to evaluate a transvaginal approach for the treatment of stress urinary incontinence in women. 1998 – present
A phase III efficacy and safety study of three fixed doses of a new sublingual medication versus placebo in the treatment of male erectile dysfunction. January 1999 – present
An eleven week, open label, placebo lead in study of two FDA approved alpha antagonists used for patients with the signs and symptoms of benign prostatic hyperplasia. 1998 – present
An open label study to evaluate patient acceptance and safety of an anticholinergic extended release medication in urge urinary incontinence. 1998 – present
A new medication versus placebo in the relief of stress urinary incontinence. 1998 – present
Double-blind, placebo controlled, safety and efficacy study of “on-demand” therapy with a new selective PDE5 Inhibitor for the treatment of male erectile dysfunction. September 1998 – December 1998
Evaluation of transurethral microwave thermotherapy in the treatment of benign prostatic hyperplasia. 1998 – present
Phase III, open label, randomized study of a new LHRH antagonist versus a LHRH agonist in patients with prostate cancer who are candidates for initial hormonal therapy. 1998 - present